News
As a board-certified family and lifestyle medicine physician in Salt Lake City, I laud both the Food and Drug Administration ...
The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal ...
The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
The nonprofit Physicians Committee for Responsible Medicine, which promotes the use of human-relevant test methods to replace ...
The FDA is phasing out animal testing for monoclonal antibody therapies, embracing AI and human-based models. Read more here.
Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their ...
The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results